StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT - Free Report) in a research report released on Monday. The brokerage issued a hold rating on the stock.
A number of other equities research analysts have also issued reports on the stock. JMP Securities reiterated a "market outperform" rating and set a $10.00 target price on shares of DBV Technologies in a report on Tuesday, December 10th. HC Wainwright boosted their price objective on shares of DBV Technologies from $25.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, October 24th.
Read Our Latest Analysis on DBV Technologies
DBV Technologies Trading Down 10.9 %
Shares of DBVT traded down $0.39 during trading hours on Monday, hitting $3.18. The company had a trading volume of 99,942 shares, compared to its average volume of 72,213. The company has a market capitalization of $65.41 million, a PE ratio of -0.71 and a beta of 0.64. DBV Technologies has a one year low of $2.20 and a one year high of $10.70. The company's fifty day moving average price is $3.46 and its two-hundred day moving average price is $3.99.
About DBV Technologies
(
Get Free Report)
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis.
Featured Stories
Before you consider DBV Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DBV Technologies wasn't on the list.
While DBV Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
